About Korro Bio, Inc. 
Korro Bio, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 22 Schemes (22.24%)
Foreign Institutions
Held by 35 Foreign Institutions (9.89%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-26 Million
Pharmaceuticals & Biotechnology
USD 309 Million (Micro Cap)
NA
0.00%
-0.82
-999,999.00%
2.69






